Dr Linda L Cunningham, MD | |
9 Alexander Avenue, Belmont, MA 02478-4802 | |
(617) 484-8235 | |
(617) 489-9600 |
Full Name | Dr Linda L Cunningham |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 9 Alexander Avenue, Belmont, Massachusetts |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376678813 | NPI | - | NPPES |
J17766 | Other | MA | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 151599 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Linda L Cunningham, MD 12 Moore St, Belmont, MA 02478 Ph: (617) 484-8235 | Dr Linda L Cunningham, MD 9 Alexander Avenue, Belmont, MA 02478-4802 Ph: (617) 484-8235 |
News Archive
A recent study conducted by a team of international scientists has revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), suppresses the expression and function of human angiotensin-converting enzyme 2 (ACE2) and induces the expression of interferon-stimulated genes at the initial phase of infection. The study is currently available on the bioRxiv* preprint server.
A large number of mouth cells exposed to e-cigarette vapor in the laboratory die within a few days, according to a study conducted by Université Laval researchers and published in the latest issue of Journal of Cellular Physiology.
Teleflex Incorporated today announced the launch of the ArrowADVANTAGE pressure-injectable peripherally inserted central catheter.
Sirnaomics, Inc. and its affiliate Suzhou Sirnaomics Pharmaceutics, Co. Ltd., together with its partner Guangzhou Xiangxue Pharmaceutical, Co. Ltd., (SZSE: 300147), have formally submitted an Investigational New Drug (IND) Application to the China Food and Drug Administration for STP705, an anti-fibrosis RNA interference (RNAi) therapeutic for prevention and treatment of human skin hypertrophic scars.
New multinational survey data released to coincide with the European Association for the Study of Diabetes (EASD) 47th Annual Meeting has revealed a lack of communication between type 2 diabetes patients and physicians around hypoglycaemia.
› Verified 6 days ago
Evan D Murray, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 115 Mill St, Mclean Hospital, Belmont, MA 02478 Phone: 617-855-2354 Fax: 617-855-3731 | |
Stephane Poulin, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Mclean Hospital, 115 Mill Street, Belmont, MA 02478 Phone: 617-855-2183 | |
Dr. Emily J Deringer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3621 | |
Dr. Marni Joy Chanoff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3937 | |
Prof. Bruce Michael Cohen, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3227 Fax: 617-855-3670 | |
John D Gambill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 29 Stults Rd, Belmont, MA 02478 Phone: 617-489-2645 | |
Ashley Beaulieu, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3117 |